protein
Putative protein-lysine deacylase ABHD14B
Gene
ABHD14B
Organism
Homo sapiens(9606)
Length
210 aa
Mass
22,346 Da
ABHD14B is a putative protein-lysine deacylase that catalyzes the deacetylation of lysine residues using CoA as a substrate, generating acetyl-CoA and free protein-lysine amines (UniProt: Q96IU4). The protein demonstrates hydrolase activity toward various p-nitrophenyl substrates in vitro with preference for p-nitrophenyl acetate, and may also function as a transcriptional activator, though in vivo confirmation of deacetylase activity remains pending (UniProt: Q96IU4).
ABHD14B is a 210-amino acid protein with no explicit disease associations recorded in UniProt. It represents a member of the ABHD family of hydrolases with putative regulatory roles in post-translational modification of cellular proteins.
ABHD14B is associated with Alzheimer's Disease and was detected as upregulated in human post-mortem AD brain tissue compared to age-matched controls (Chaparral AD proteomics). Analysis of TMT-labeled proteomics across four subcellular fractions showed a mean log2 fold-change of 0.91, indicating modest elevation in AD brain. This upregulation may reflect altered protein deacetylation pathways relevant to AD pathobiology, though functional significance in disease progression remains to be established.
Generated from the curated entity record below. May contain errors — verify against source links.
Proteomics Evidence · AD
↑ Up in ADP3
+0.911
P2
not detected
S2
not detected
S3
not detected
Mean log₂FC across detected fractions: +0.9115 (1 of 4 fractions detected)
Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.
Related Publications
Browse all →Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Dujardin Simon et al.Nature medicine2020PMID 32572268Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
Bai Bing et al.Neuron2020PMID 31926610A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried Nicholas T et al.Cell systems2017PMID 27989508Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.
Johnson Erik C B et al.Nature neuroscience2022PMID 35115731Organization and regulation of gene transcription.
Cramer PatrickNature2019PMID 31462772
Function
Acts as an atypical protein-lysine deacetylase in vitro (PubMed:31478652). Catalyzes the deacetylation of lysine residues using CoA as substrate, generating acetyl-CoA and the free amine of protein-lysine residues (PubMed:31478652). Additional experiments are however required to confirm the protein-lysine deacetylase activity in vivo (Probable). Has hydrolase activity towards various surrogate p-nitrophenyl (pNp) substrates, such as pNp-butyrate, pNp-acetate and pNp-octanoate in vitro, with a strong preference for pNp-acetate (PubMed:14672934, PubMed:31478652). May activate transcription (PubMed:14672934)
Sources
Last updated 5/8/2026, 6:38:55 AM
